2,554 Shares in Danaher Co. (NYSE:DHR) Bought by Trust Point Inc.

Trust Point Inc. acquired a new position in shares of Danaher Co. (NYSE:DHR) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 2,554 shares of the conglomerate’s stock, valued at approximately $591,000.

Other hedge funds have also recently bought and sold shares of the company. DHJJ Financial Advisors Ltd. purchased a new position in Danaher during the 3rd quarter worth $25,000. BKM Wealth Management LLC bought a new stake in shares of Danaher during the 4th quarter worth $27,000. OFI Invest Asset Management bought a new stake in shares of Danaher during the 3rd quarter worth $30,000. First Capital Advisors Group LLC. bought a new stake in shares of Danaher during the 2nd quarter worth $32,000. Finally, BOK Financial Private Wealth Inc. bought a new stake in shares of Danaher during the 3rd quarter worth $34,000. 79.05% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Danaher

In other Danaher news, SVP Georgeann Couchara sold 2,622 shares of the business’s stock in a transaction dated Tuesday, February 13th. The stock was sold at an average price of $242.67, for a total transaction of $636,280.74. Following the sale, the senior vice president now owns 4,244 shares in the company, valued at approximately $1,029,891.48. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In other news, Director Teri List sold 3,289 shares of the company’s stock in a transaction dated Tuesday, February 6th. The stock was sold at an average price of $248.32, for a total value of $816,724.48. Following the sale, the director now owns 19,726 shares in the company, valued at $4,898,360.32. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Georgeann Couchara sold 2,622 shares of the company’s stock in a transaction dated Tuesday, February 13th. The stock was sold at an average price of $242.67, for a total value of $636,280.74. Following the completion of the sale, the senior vice president now owns 4,244 shares in the company, valued at approximately $1,029,891.48. The disclosure for this sale can be found here. Insiders have sold 32,957 shares of company stock valued at $8,265,802 in the last ninety days. Corporate insiders own 11.10% of the company’s stock.

Danaher Stock Down 1.0 %

NYSE DHR opened at $241.93 on Friday. The stock’s 50-day moving average price is $249.21 and its 200-day moving average price is $230.46. The company has a market capitalization of $179.16 billion, a P/E ratio of 37.86, a price-to-earnings-growth ratio of 3.74 and a beta of 0.83. Danaher Co. has a 52 week low of $182.09 and a 52 week high of $259.00. The company has a quick ratio of 1.37, a current ratio of 1.68 and a debt-to-equity ratio of 0.31.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Tuesday, January 30th. The conglomerate reported $2.09 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.91 by $0.18. The company had revenue of $6.41 billion during the quarter, compared to analysts’ expectations of $6.10 billion. Danaher had a return on equity of 12.25% and a net margin of 17.26%. Danaher’s revenue was down 10.2% compared to the same quarter last year. During the same quarter in the previous year, the business earned $2.87 EPS. On average, equities research analysts predict that Danaher Co. will post 7.62 earnings per share for the current year.

Danaher Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, April 26th. Investors of record on Thursday, March 28th will be given a dividend of $0.27 per share. This is a positive change from Danaher’s previous quarterly dividend of $0.24. This represents a $1.08 annualized dividend and a yield of 0.45%. The ex-dividend date is Wednesday, March 27th. Danaher’s dividend payout ratio is currently 16.90%.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently commented on DHR shares. Raymond James lifted their target price on Danaher from $240.00 to $270.00 and gave the stock an “outperform” rating in a research note on Wednesday, January 31st. StockNews.com cut Danaher from a “buy” rating to a “hold” rating in a research note on Wednesday, January 31st. KeyCorp boosted their price objective on Danaher from $260.00 to $290.00 and gave the company an “overweight” rating in a research note on Thursday, February 1st. Citigroup boosted their price objective on Danaher from $255.00 to $280.00 and gave the company a “buy” rating in a research note on Wednesday, January 31st. Finally, TheStreet upgraded Danaher from a “c+” rating to a “b-” rating in a research report on Friday, December 8th. Seven analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. According to MarketBeat, Danaher presently has a consensus rating of “Moderate Buy” and a consensus price target of $266.00.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.